NEW YORK (Reuters Health) – Smoking does not affect platelet reactivity or clinical effectiveness in patients who have received clopidogrel, according to a report in the August 11th…
NEW YORK (Reuters Health) – A closed-loop hydration and fluid balancing system protects against contrast-induced acute kidney injury in high-risk patients, according to results of a study published…
NEW YORK (Reuters Health) – Currently available evidence supports pulse oximetry screening of newborns for low blood oxygen saturation to detect critical congenital heart disease (CCHD), according to…
NEW YORK (Reuters Health) – Measuring homocysteine improves the accuracy of estimated risk of cardiovascular events, according to an analysis of data from two different sources. “Our observations…
Jonathan Piccini, MD, MHS discusses evaluating superiority vs non-inferiority in clinical trials, as reported in Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, M.D.,…
NEW YORK (Reuters Health) – The beta-blocker propranolol is superior to traditional first-line oral corticosteroids in the treatment of infantile hemangiomas (IHs), conclude pediatric dermatologists from Miami, Florida.…
NEW YORK (Reuters Health) – Among patients undergoing cardiac procedures, a lower dose of contrast medium based on calculated creatinine clearance may reduce the risk of contrast-induced nephropathy,…
Discussion surrounding dose adjustment for renal insufficiency as reported in Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, M.D., Kenneth W. Mahaffey, M.D., Jyotsna Garg, M.S.,…
NEW YORK (Reuters Health) – Perioperative treatment with low-dose human atrial natriuretic peptide (carperitide) improves outcomes in patients with chronic kidney disease (CKD) who are undergoing coronary artery…
NEW YORK (Reuters Health) – An updated guideline on the management of chronic heart failure by the UK’s National Institute for Health and Clinical Excellence (NICE) addresses changes…